Problem 12-5 Computing ROl and RI (LO2 - CC4, 6) Financial data for Joel de...

50.1K

Verified Solution

Question

Accounting

imageimage

Problem 12-5 Computing ROl and RI (LO2 - CC4, 6) Financial data for Joel de Paris Inc. for last year follow: JOEL DE PARIS INC. Balance Sheet Ending Balance Beginning Balance Assets Cash Accounts receivable Inventory Plant and equipment, net Investment in Buisson, S.A Land (undeveloped) $ 500,000 $ 750,000 1,750,000 1,000,000 1,500,000 360,000 260,000 1,500,000 1,000,000 2,000,000 395,000 240,000 Total assets $5,635,000 $5,620,000 Liabilities and Shareholders' Equity Accounts payable Long-term debt Shareholders' equity $ 947,200 $1,035,000 4,140,000 445,000 3,788,800 899,000 Total liabilities and shareholders' equity $5,635,000 $5,620,000 JOEL DE PARIS INC Income Statement Sales Less: Operating expenses $6,500,000 5,200,000 Net operating income Less: Interest and taxes: 1,300,000 Interest expense Tax expense $477,000 349,000 826,000 Net income $ 474,000 The company paid dividends of $20,000 last year. The "Investment in Buisson, S.A." on the balance sheet represents an investment in the shares of another company. Required: 1. Compute the company's margin, turnover, and ROI for last year. (Do not round intermediate calculations. Round your answers to 2 decimal place.) Margin Turnover ROI 2. The board of directors of Joel de Paris Inc. has set a minimum required return of 21%. What was the company's residual income last year? Residual income

Answer & Explanation Solved by verified expert
Get Answers to Unlimited Questions

Join us to gain access to millions of questions and expert answers. Enjoy exclusive benefits tailored just for you!

Membership Benefits:
  • Unlimited Question Access with detailed Answers
  • Zin AI - 3 Million Words
  • 10 Dall-E 3 Images
  • 20 Plot Generations
  • Conversation with Dialogue Memory
  • No Ads, Ever!
  • Access to Our Best AI Platform: Flex AI - Your personal assistant for all your inquiries!
Become a Member

Other questions asked by students